A second concern raised by Ms Lavallee is the presence or absence of comorbid conditions in the ADHD probands and/or the non-ADHD comparison children. Samples in molecular genetic studies of ADHD vary considerably in the treatment of overlapping diagnostic conditions in participants. A number of investigators 7, 8 have sampled more or less 'pure' ADHD groups, whereas other researchers [3] [4] [5] 9 have sampled ADHD children with overlapping disorders. Although the choice of a particular sample is often a matter of scientific focus and reflects the specific questions one is attempting to answer, different sampling alternatives have distinct advantages and limitations. The obvious advantage of a 'pure' ADHD sample is that any relation found with a gene can be attributable to ADHD per se, and cannot be due merely to other disorders that overlap with ADHD. The disadvantages of 'pure' ADHD samples may be less obvious, however. Studies have documented considerable overlap between ADHD and Oppositional Defiant Disorder and Conduct Disorder, as well as anxiety disorders and depression.
A second concern raised by Ms Lavallee is the presence or absence of comorbid conditions in the ADHD probands and/or the non-ADHD comparison children. Samples in molecular genetic studies of ADHD vary considerably in the treatment of overlapping diagnostic conditions in participants. A number of investigators 7, 8 have sampled more or less 'pure' ADHD groups, whereas other researchers [3] [4] [5] 9 have sampled ADHD children with overlapping disorders. Although the choice of a particular sample is often a matter of scientific focus and reflects the specific questions one is attempting to answer, different sampling alternatives have distinct advantages and limitations. The obvious advantage of a 'pure' ADHD sample is that any relation found with a gene can be attributable to ADHD per se, and cannot be due merely to other disorders that overlap with ADHD. The disadvantages of 'pure' ADHD samples may be less obvious, however. Studies have documented considerable overlap between ADHD and Oppositional Defiant Disorder and Conduct Disorder, as well as anxiety disorders and depression. 10 Given this substantial overlap, many more ADHD probands would need to be sampled to acquire a 'pure' ADHD sample than a sample in which overlapping disorders were represented. Sampling children who may have disorders in addition to ADHD also allows one to test whether the same genes that influence ADHD also influence the overlapping disorders. In addition, given that most ADHD children also have other diagnoses, 'pure' ADHD samples are likely to be highly non-representative of the general ADHD population.
A third point raised by Ms Lavallee is her suggestion that samples in molecular genetic studies of ADHD be recruited on the basis of genotype rather than phenotype. There may indeed be some advantages associated with randomly sampling individuals from a large, nonreferred population. These would include avoiding a number of concomitant characteristics of clinical samples (eg, greater impairment, higher degrees of diagnostic overlap) and potentially examining a broader range of symptom severity. Despite these advantages, sampling by genotype rather than phenotype poses a number of serious limitations that would be very difficult to surmount. First, the design that Ms Lavallee proposes is a 6 × 3 factorial design of six DRD4 genotypes (including the 2/7 DRD4 genotype that she inadvertently omitted) and three DRD2 genotypes to accommodate only these two genes (viz, DRD4 and DRD2). Under this sampling scheme, one must adequately fill 18 cells, which would require a prohibitively large number of participants. These formidable sampling requirements are only compounded by the relative rarity of several genotypes (eg, the DRD4 7/7 and DRD2 A1/A1; not to mention the conjunction of these!). For example, in our recent study 3 to which Ms Lavallee is responding, the frequency of the DRD4 7/7 genotype in non-disordered controls was only 4%. In addition, in a mixed clinical and non-disordered control sample from our study, the frequency of the A1/A1 genotype was just less than 2%. This problem regarding genotypic frequencies is only compounded by taking into account issues concerning the phenotype. A number of authors 11, 12 have shown that most of the information for genetic linkage comes from individuals who are extremely low or extremely high (eg, the bottom and top 10%) on the phenotype being examined, such that statistical power can be very low unless sampling is from the phenotypic extremes (eg, sampling highly concordant and highly discordant sib pairs). 13 Thus, although it already would be very difficult to sample adequately on the basis of genotype, in order to represent individuals at the phenotypic extremes and have sufficient statistical power, one would need an initial sample that is so large as to be infeasible. It is these issues that undergird most of the current sampling strategies in contemporary molecular genetic studies of both psychiatric and medical disorders. Inevitably there are difficulties in knowing how best to match control groups including matching for comorbidity. Studies which use internal controls eg TDT overcome the potential problem of false positives due to population stratification. Nevertheless replication by other groups is still essential before findings are accepted. Ms Lavallee suggests that, instead of using the traditional case-control design, a population-based sample should be recruited. With a sufficiently large sample, the full range of behavioural symptoms would be observed and could be related to the DRD4 and DRD2 genotypes of the study participants in the way suggested. Although this design is an appealing way of avoiding the difficult problem of selecting appropriate controls, we question the feasibility of obtaining a large enough sample to make this realistic. Relatively few children would exhibit clinically significant ADHD symptoms, and very many children would need to be genotyped to see sufficient examples of rare genotypes such as DRD4 7,7.
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A further problem is that even a cohort design does not avoid the problem of confounding. Extremely large samples would be required to stratify for the effects of factors such as comorbidity, gender as well as other potential influences such as IQ.
Although it is often possible to adjust for confounders in the analysis, population stratification due to ethnicity can generally only be allowed for by crude measures. The large differences in the distribution of the DRD4 polymorphism in different ethnic groups make this a very important consideration. For this reason we favour family-based case-control studies as the most suitable way forward.
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Castellanos replies
SIR -While we attempted to correlate phenotype with genotype 1 as a way of evaluating the magnitude of the effect of a putative susceptibility allele for ADHD, the widespread application to such a complex genetic disorder of the factorial design proposed by Ms Lavallee is premature and impractical. Without even considering the exceedingly low prior probabilities of nearly all current candidate gene studies, 2 such factorial designs would require much larger samples than are currently available to investigators. For example, the worldwide frequency of the 2-repeat DRD4 allele is 0.082 (SE 0.14), so that fewer than seven individuals per thousand would be expected to be homozygous for this variant. Furthermore, the DRD4 gene is particularly diverse among different ethnic groups, and the frequency of the 2-repeat allele varies between undetectable in some populations and 0.42 in Samoans. 3 Therefore, when such ambitious studies are eventually undertaken the use of appropriate genetic isolates may be extremely helpful. Selection bias of susceptibility genes possible when using parent-offspring trios in genetic association studies SIR -For a number of reasons association studies have increasingly been applied in the ongoing efforts to identify susceptibility genes involved in psychiatric disorders. Simulation studies have suggested that minor susceptibility genes might perhaps only, or more easily, be identified by association studies rather than by either the lod score or affected sib-pair method of linkage analysis. 1, 2 Case control association studies of supposed candidate genes have been used far more frequently due to availability and relative ease of collecting such samples.
However, the use of case control association studies has been heavily criticized for several reasons, especially due to the risk of population stratification problems and the probable low a priori relevance of many or all of the presently known candidate genes investigated for most psychiatric disorders. 3, 4 In order to avoid spurious association caused by different frequency of disease and marker alleles in hidden subpopulations, other approaches for selecting controls have been proposed. These methods use data from nuclear families with one affected child. The parents' non-transmitted alleles form the control sample, ie the case and control sample derive from the same genetic population. 5, 6 The use of such methods has strongly been recommended for genetic mapping of susceptibility genes by prominent researchers. 7, 8 Such a design has also been advocated for testing genotype-environment interaction. 9 Furthermore, there has been a tendency to regard results from such studies as more valid compared to results from case control studies. 10, 11 It has even been suggested to refuse acceptance of scientific papers reporting case-control genetic association studies of complex traits. 12 However, we believe that case control studies are necessary and that trios may represent a selected sample of patients for at least bipolar disorder and schizophrenia. These two study designs may potentially include patient samples differing not only on demographic factors but also on the specific risk genes and perhaps even on environmental risk factors involved. This selection bias could lead to wrong or differing conclusions in trio samples compared to single cases, which are more numerous, and thus, potentially, more representative at least for bipolar disorder and schizophrenia.
Selection bias is possible when using trios for association studies if patients with two participating parents differ from patients with no or only one participating parent on a number of genetically influenced phenotypical characteristics.
The age of the patient at the time of inclusion in the investigation, and thus the patient's age of onset, is also
